🛍️ Amazon Big Spring Sale: 100+ editor-approved deals worth buying right now 🛍️ By Mack DeGeurin Published Mar 13, 2026 3:00 PM EDT Add Popular Science (opens in a new tab) Adding us as a Preferred ...

Hospital intensive care units are notoriously noisy, with medical equipment emitting alarms, beeps, and other alerts designed to grab the attention of overextended healthcare workers. That constant ...

Artificial intelligence isn't new to food R&D: McCormick, which owns brands including Frank's RedHot, Cholula and Old Bay, has been using AI in flavor development for a decade. Unilever says its ...

Wix announced the launch of Wix Harmony, a new AI-powered website builder that combines natural language site creation with Wix’s existing visual editor. The company introduced the product in New York ...

In a move that completely undermines the “Tesla is an AI company” narrative, Elon Musk’s private startup, xAI, has reportedly told investors that it plans to build the AI to power Tesla’s Optimus ...

GeneDx’s Infinity™ will leverage insights from Komodo’s Healthcare Map ® to unlock faster health economics and outcomes research (HEOR), biopharma innovation, and AI-driven discovery GAITHERSBURG, Md.

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a strategic partnership with Komodo Health, the ...

GeneDx’s Infinity™ will leverage insights from Komodo’s Healthcare Map® to unlock faster health economics and outcomes research (HEOR), biopharma innovation, and AI-driven discovery GeneDx (Nasdaq: ...

Opal is now inside the Gemini web app, which means you can build reusable AI mini-apps right where you already manage Gems. If you’ve been waiting for an easier way to create custom Gemini tools ...

Eli Lilly has unveiled the location of the third of its four large-scale manufacturing facilities that it plans to build in the U.S. The drugmaker has selected Huntsville, Alabama, as the site of a $6 ...

Cell and gene therapy (CGT) has evolved from a niche research pursuit into a central force in biopharmaceutical innovation. By engineering living cells and genetic material to repair or replace faulty ...